Scheduling of anticancer drugs: timing may be everything

Astrid A M Van der Veldt; Adriaan A Lammertsma; Egbert F Smit

doi:10.4161/cc.22187

Scheduling of anticancer drugs: timing may be everything

Astrid A M Van der Veldt^*, Adriaan A Lammertsma, Egbert F Smit

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Abstract

Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.

Original language	English
Pages (from-to)	4339-4343
Number of pages	5
Journal	Cell Cycle
Volume	11
Issue number	23
DOIs	https://doi.org/10.4161/cc.22187
Publication status	Published - 3 Oct 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/cc.22187

Cite this

@article{b384f0249fbc4f42829f07eeb860ae1f,

title = "Scheduling of anticancer drugs: timing may be everything",

abstract = "Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.",

author = "{Van der Veldt}, {Astrid A M} and Lammertsma, {Adriaan A} and Smit, {Egbert F}",

year = "2012",

month = oct,

day = "3",

doi = "10.4161/cc.22187",

language = "English",

volume = "11",

pages = "4339--4343",

journal = "Cell Cycle",

issn = "1538-4101",

publisher = "Taylor & Francis Ltd",

number = "23",

}

TY - JOUR

T1 - Scheduling of anticancer drugs

T2 - timing may be everything

AU - Van der Veldt, Astrid A M

AU - Lammertsma, Adriaan A

AU - Smit, Egbert F

PY - 2012/10/3

Y1 - 2012/10/3

N2 - Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.

AB - Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.

U2 - 10.4161/cc.22187

DO - 10.4161/cc.22187

M3 - Article

C2 - 23032365

SN - 1538-4101

VL - 11

SP - 4339

EP - 4343

JO - Cell Cycle

JF - Cell Cycle

IS - 23

ER -

Scheduling of anticancer drugs: timing may be everything

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this